Clinical evaluation of antifungal agents for the treatment and prophylaxis invasive fungal disease - Scientific guideline

This document addresses the clinical development of antifungal agents for the treatment and prophylaxis of invasive fungal disease.

Keywords: Invasive fungal disease (IFD), rapid diagnostic tests, combination regimens, salvage therapy, patients with febrile neutropenia, fungaemia

Current effective version

Guideline on the clinical evaluation of antifungal agents for the treatment and prophylaxis of invasive fungal disease

AdoptedLegal effective date: 01/11/2010Reference Number: CHMP/EWP/1343/01 Rev. 1

Document history - Revision 1

Guideline on the clinical evaluation of antifungal agents for the treatment and prophylaxis of invasive fungal disease

AdoptedLegal effective date: 01/11/2010Reference Number: CHMP/EWP/1343/01 Rev. 1

Overview of comments received on ' Guideline on the clinical evaluation of antifungal agents for the treatment and prophylaxis of invasive fungal disease' (CHMP/EWP/1343/01 Rev.1)

Reference Number: EMA/186797/2010

Draft guideline on the clinical evaluation of antifungal agents for the treatment and prophylaxis of invasive fungal disease

Draft: consultation closedReference Number: CHMP/EWP/1343/01 Rev. 1

Document history - First version

Points to consider on the clinical evaluation of new agents for invasive fungal infections

AdoptedLegal effective date: 01/11/2003Reference Number: CPMP/EWP/1343/01